Perrigo Launches Generic Neptazane Tablets

Perrigo Received FDA Approval for Generic Prandin
Perrigo Received FDA Approval for Generic Prandin

Perrigo announced the launch of Methazolamide Tablets, the generic version of Fera's Neptazane.

Methazolamide is a carbonic anhydrase inhibitor indicated for the treatment of ocular conditions where lowering intraocular pressure would be of therapeutic benefit (eg, chronic open-angle glaucoma, secondary glaucoma, pre-op in acute angle-closure glaucoma). Its inhibitory action on carbonic anhydrase decreases the secretion of aqueous humor and results in a decrease in intraocular pressure.

RELATED: Ophthalmic Disorders Resource Center

Perrigo's Methazolamide Tablets are a part of the contingent rights received in connection with its acquisition of the ophthalmic portfolio from Fera and its affiliates.

For more information call (866) 634-9120 or visit Perrigo.com.

Loading links....